Cooper Companies | COO - Ebitda



Cooper Companies reported $272.7M in EBITDA for its fiscal quarter ending in July of 2025.


Ebitda Change Date
Abbott USD 3.05B 870M Jun/2025
Align Technology USD 137.61M 77.61M Mar/2025
AtriCure USD 15.35M 16.22M Jun/2025
Avanos Medical USD -63900000 85.5M Jun/2025
Bausch Health Companies USD 912M 315M Jun/2025
Baxter International USD 325M 251M Mar/2025
Bayer EUR 236M 3.35B Jun/2025
Becton, Dickinson and Co. USD 1.47B 81M Jun/2025
Boston Scientific USD 1.36B 16M Mar/2025
Cooper Companies USD 272.7M 5.8M Jul/2025
Dentsply International USD 197M 45M Jun/2025
Dexcom USD 308.8M 115.1M Jun/2025
Edwards Lifesciences USD 411.3M 15.3M Mar/2025
Globus Medical USD 208.68M 44.48M Jun/2025
Haemonetics USD 106.31M 6.77M Jun/2025
Hologic USD 334M 26.7M Jun/2025
Insulet USD 157.5M 47M Jun/2025
Integra LifeSciences USD -472218000 536.09M Jun/2025
Intuitive Surgical USD 898.7M 317.2M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Medtronic USD 2.31B 400M Jul/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
Novartis USD 6.08B 739M Jun/2025
ResMed USD 540.03M 61.85M Jun/2025
STAAR Surgical USD -14939000 17.46M Jun/2025
Steris USD 353.78M 33.81M Mar/2025
Stryker USD 1.46B 49M Jun/2025
Tandem Diabetes Care USD -1851000 28.33M Jun/2025
Teleflex USD 222.67M 27.85M Jun/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025